Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Ravish Katira"'
Autor:
Arnav Katira, Ravish Katira
Publikováno v:
Postgraduate Medical Journal. 98:718-721
Coronary artery disease (CAD) is a major cause of morbidity and mortality worldwide. Inflammation has been seen to be a key feature of atherosclerosis and CAD, with a raised C-reactive protein being a marker of poor prognosis. Thus, the role of anti-
Publikováno v:
BMJ Case Rep
A man in his late 60s with a significant history of decompensated alcohol-related liver disease was admitted to hospital with a 2-week history of increasing jaundice and pruritus as well as confusion, drowsiness and a decreased exercise tolerance. Ro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce58ebe07961a53f32000147247756a8
https://europepmc.org/articles/PMC8217942/
https://europepmc.org/articles/PMC8217942/
Autor:
Kai Wen Chen, Ahmed Farouk Mohamed Elamin, Toba Obafemi, Ahai Luvai, Ciaran Grafton-Clarke, Ravish Katira, Gershan Davis
Publikováno v:
Postgraduate medical journal. 95(1120)
Background Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors are a major development in the prevention of cardiovascular disease (CVD) and is one of the most significant discoveries since the development of statin therapy. Administrati
Autor:
Arnav Katira, Ravish Katira
Publikováno v:
Practical Diabetes. 36:222
Publikováno v:
British Journal of Hospital Medicine. 70:704-707
Sleep-disordered breathing is a spectrum of disorders. As our knowledge of sleep medicine is improving, the strong association of sleep-disordered breathing with cardiac disorders is being recognized. This article discusses the association of sleep-d
Publikováno v:
Breathe. 3:89-92
A 42-year-old Caucasian female was admitted to hospital with a history of dyspnoea at rest. Apart from a history of nodular prurigo for which she used topical steroid creams, the patient was generally healthy. The patient reported that shortness of b
Publikováno v:
Primary Care Respiratory Journal. 11:125-127
Publikováno v:
Postgraduate medical journal. 81(956)
Antithrombotic agents have verified efficacy in reducing the thromboembolic risk associated with atrial fibrillation. This article focuses on the emergence of a new oral direct thrombin inhibitor, ximelagatran, into the arena of atrial fibrillation t